Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rafael Prieto

Physical Medicine & Rehabilitation Nashville, TN Medical Doctor

NPI 1699710426 CMS profile 1294375

3443 Dickerson Pike Ste 730, Nashville, TN 37207

Open in the dashboard

General payments

$3,916

194 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rafael Prieto of Nashville, TN is reported in the CMS Open Payments database as having received $3,916 across 194 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $46 1
2022 General $299 17
2021 General $888 50
2020 General $747 63
2019 General $1,936 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rafael Prieto
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Rafael Prieto were reported at $46. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Rafael Prieto Physical Medicine & Rehabilitation median Middle half National median
2019 $1,936 $133 $45–$390 $163
2020 $747 $88 $29–$272 $114
2021 $888 $116 $33–$360 $132
2022 $299 $123 $40–$378 $149
2023 $0 $131 $43–$396 $160
2024 $0 $141 $45–$409 $164
2025 $46 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $1,264 18 payments
  2. Collegium Pharmaceutical, Inc. $672 44 payments
  3. Scilex Pharmaceuticals Inc. $502 26 payments
  4. Salix Pharmaceuticals, a division of Bausch Health US, LLC $318 18 payments
  5. Boston Scientific Corporation $181 7 payments
  6. Pfizer Inc. $177 15 payments
  7. Zyla Life Sciences $170 28 payments
  8. Abbott Laboratories $134 7 payments
  9. Biodelivery Sciences International, Inc. $104 6 payments
  10. Daiichi Sankyo Inc. $79 5 payments
  11. Other $315 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,066 191 payments
  2. Travel and Lodging $834 2 payments
  3. Education $16 1 payment
Products named General payments · program years 2019–2025
  1. Senza Spinal Cord Stimulation System $1,250 17 payments
  2. XTAMPZA $656 43 payments
  3. ZTLido $389 20 payments
  4. RELISTOR Gastroenterology $259 14 payments
  5. SPRIX $154 27 payments
  6. EMBEDA $123 11 payments
  7. LYRICA $101 10 payments
  8. BELBUCA $85 5 payments
  9. Morphabond ER $79 5 payments
  10. RELISTOR Gastroenterology $60 4 payments
  11. Other $934 52 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

194 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record